NCT05948462 Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent Lorlatinib Status WITHDRAWN Phase PHASE2
NCT05946460 Neoadjuvant Aumolertinib in Patients With AI-diagnosed EGFR-mutant High-risk Pulmonary Ground-glass Opacity. Status RECRUITING Phase PHASE2
NCT05937477 Developing Artificial Intelligence-based Algorism to Predict Side Effects and Symptoms From Chemotherapy Status RECRUITING Phase N/A
NCT05931445 Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT05928299 Integrative Multi-Omics Testing for Immunotherapy Response in Non-Small Cell Lung Cancer Status COMPLETED Phase N/A
NCT05926336 The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action Status RECRUITING Phase PHASE4
NCT05919147 The Neuroendocrine Effects of Pioglitazone in Patients With Cancer and Cachexia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05904574 Effectiveness of the Autologous Blood Patch Method in Lung Biopsies Status COMPLETED Phase N/A
NCT05903430 A Feasibility Study of MRI Guided Stereotactic Ablative Radiotherapy (MIDSECTION) Status RECRUITING Phase N/A
NCT05902559 Assessment of Novel Biomarkers in Participants Undergoing Targeted Lung Health Checks Status RECRUITING Phase N/A
NCT05902520 Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05899270 3D-printed Reconstruction Automated Matching System Predicts Size of Double-lumen Tube: a Prospective Double-blinded Randomized Controlled Trial Status UNKNOWN Phase NA
NCT05890820 The Effect of Nutritional Risk Parameters on Postoperative Pulmonary Complications in Geriatric Thoracic Surgery Cases Status UNKNOWN Phase N/A
NCT05888584 Improving Access and Recruitment to Clinical Trials for Lung Cancer Patients Status COMPLETED Phase NA
NCT05887492 Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2